← Oncology Approval Tracker

FDA DECISION ·

Ibtrozi

taletrectinib · Nuvation Bio

FDA approvalNew therapyNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with ROS1-positive NSCLC that is locally advanced or metastatic.

LAMPGEN ANALYSIS

Why it matters

This ROS1 kinase inhibitor was evaluated in both ROS1 inhibitor-naive and previously exposed populations.

What research teams should watch

Confirm the ROS1 result and prior targeted therapy history; coordinate liver and ECG monitoring where appropriate.

PRIMARY RECORDS

Sources